🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NVC
$NVCT
🔒 US EquitiesNuvectis Pharma Inc
AVG HISTORICAL GAP
-1.76%
MAX GAP RECORD
-10.83%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NVCT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NVCT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 03, 2026 Earnings Release 2026-11-03 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 04, 2026 Earnings Release 2026-08-04 (BEFORE OPEN) |
-10.83%
|
| May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN) |
-0.11%
|
| Feb 11, 2026 Earnings Release 2026-02-11 (BEFORE OPEN) |
+1.26%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN) |
-2.36%
|
| Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN) |
-1.78%
|
| May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN) |
+2.45%
|
| Feb 25, 2025 Earnings Release 2025-02-25 (BEFORE OPEN) |
-1.36%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.3%
Bullish Gaps (2)
Bearish Gaps (9)
Neutral / Flat (4)
📖 Intelligence Summary
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗